Pascal Madeleine Fisemou

About Marcad

The Malaria Research Capacity Development Consortium (MARCAD) seeks to train a core group of African scientists in West and Central Africa who will be able to provide relevant answers for the control and elimination of malaria. One PhD and two post-docs fellows are hosted at each partner institution across five African countries (Mali, The Gambia, Cameroon, Ghana and Senegal).

The University Cheikh Anta Diop UCAD, Senegal (Prof O. Gaye) leads the Consortium which includes USTTB, Mali (Prof OK. Doumbo); MRC, The Gambia (Prof U. D'Alessandro); UY1, Cameroon (Prof W. Mbacham) and UHAS, Ghana (Prof HK. Tagbor). Three European institutions collaborate in this programme: LSHTM-UK, LSTM-UK and UoC, Denmark.

Pascal Madeleine Fisemou

Host institution : Biotechnology Center, University of Yaoundé I Cameroon

Project title: Genomic evaluation of Plasmodium falciparum and Schistosoma sp in co-infected children in Seasonal Malaria Chemoprevention (SMC) area in Cameroon

Biography

Pascal Fisemou obtained his bachelor’s degree in Biological Sciences from the University of Maroua, Far North Cameroon, and a master’s degree in Biochemistry with a specialty in Biotechnology from the University of Yaoundé 1, Cameroon. He is currently pursuing doctoral research under the MARCAD-Plus fellowship program, with a particular focus on tropical diseases such as malaria and Schistosomiasis, also known as Bilharzia, which are classified as neglected tropical diseases.

His research centers on the genomic evaluation of Plasmodium falciparum and Schistosoma sp in co-infected children in areas undergoing Seasonal Malaria Chemoprevention (SMC) in Cameroon. Specifically, Pascal is investigating the interaction between these parasites, employing bioinformatics tools to analyse their transcriptomic regulation profiles, copy number variation (CNV), similarities between their antigens, and identifying newly expressed resistance genes against drugs.

A dedicated research enthusiast, Pascal has been a member of the Royal Society of Tropical Medicine and Hygiene (RSTMH) since 2023. He is also affiliated with the Laboratory for Public Health Research Biotechnology (LAPHER-Biotech) at the University of Yaoundé 1 and serves as a researcher at the Centre for Health Implementation and Translational Research (CHITRES) at Fobang Institutes (FINISTECH). In this capacity, he oversees recruitment and field data collection for the project "Impact evaluation of intermittent preventive treatment of malaria in infants plus (PMC) in Cameroon."

Following the completion of his Ph.D., Pascal aims to further deepen his expertise through a postdoctoral position, with the aspiration of becoming an independent researcher dedicated to contributing to the elimination of malaria and neglected tropical diseases.

MARCAD PLUS PROGRAM
MARCAD DIRECTOR PR GAYE INTERVIEW

MARCAD PLUS SELECTED FOR DELTAS AFRICA II PROGRAM

MARCAD Plus is a consortium of institutions putting together their capacities to contribute significatively to malaria and NTDs elimination in West and Central Africa. MARCAD Plus is sponsored by the Welcome Trust and the Foreign, Commonwealth & Development Office (FCDO), working in partnership with the Science for Africa Foundation (SFA)

The MARCAD Plus program
Malaria and NTDs Research Capacity Development (MARCAD Plus) in West and Central Africa is among the 14 consortia selected for the second phase of The Developing Excellence in Leadership, Training, and Science in Africa (DELTAS Africa) programme. The DELTAS Africa II launch ceremony was held on March 14th, 2023, in Nairobi, Kenya. READ MORE INFORMATIONS
For Malaria elimination in Africa

MARCAD Director Pr Gaye interview with the Senegalese national press newspaper about the next DELTASAfrica meeting in Dakar ( from 15th to 17th july) and the importance of DeltasAfrica programme for the Continent.